The method of minimization for allocation to clinical trials. a review.

[1]  Anthony C. Atkinson,et al.  The comparison of designs for sequential clinical trials with covariate information , 2002 .

[2]  D. Bick,et al.  Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a randomised controlled trial , 2001, The Lancet.

[3]  B. Byrom,et al.  Minimization in crossover trials with non‐prognostic strata: theory and practical application , 2001, Journal of clinical pharmacy and therapeutics.

[4]  Stephen Senn Consensus and Controversy in Pharmaceutical Statistics , 2000 .

[5]  Dongsheng Tu,et al.  Adjustment of Treatment Effect for Covariates in Clinical Trials: Statistical and Regulatory Issues , 2000 .

[6]  S A Hamilton,et al.  Dynamically allocating treatment when the cost of goods is high and drug supply is limited. , 2000, Controlled clinical trials.

[7]  M. Rovers,et al.  USING A BALANCING PROCEDURE IN MULTICENTER CLINICAL TRIALS , 2000, International Journal of Technology Assessment in Health Care.

[8]  A. Steptoe,et al.  Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease: randomised trial. , 1999, BMJ.

[9]  J. Lewis,et al.  Statistical principles for clinical trials (ICH E9): an introductory note on an international guideline. , 1999, Statistics in medicine.

[10]  A. Atkinson,et al.  Optimum biased-coin designs for sequential treatment allocation with covariate information. , 1999, Statistics in medicine.

[11]  C. Viscoli,et al.  Stratified randomization for clinical trials. , 1999, Journal of clinical epidemiology.

[12]  T. Treasure,et al.  Minimisation: the platinum standard for trials? , 1998, BMJ.

[13]  S Senn,et al.  A personal view of some controversies in allocating treatment to patients in clinical trials. , 1995, Statistics in medicine.

[14]  Val Gebski,et al.  Dynamic balanced randomization for clinical trials , 1993 .

[15]  T M Therneau,et al.  How many stratification factors are "too many" to use in a randomization plan? , 1993, Controlled clinical trials.

[16]  P van den Broek,et al.  The choice of a balanced allocation method for a clinical trial in otitis media with effusion. , 1990, Statistics in medicine.

[17]  D. G. Altman,et al.  Randomisation and baseline comparisons in clinical trials , 1990, The Lancet.

[18]  A. Pearce,et al.  Treatment allocation in clinical trials : randomisation and minimisation compared in three test cases , 1990 .

[19]  M. Hochberg,et al.  Clinical trials. A guide to understanding methodology and interpreting results. , 1990, Arthritis and rheumatism.

[20]  J P Matts,et al.  Randomization in clinical trials: conclusions and recommendations. , 1988, Controlled clinical trials.

[21]  L A Kalish,et al.  Efficiency of balanced treatment allocation for survival analysis. , 1988, Biometrics.

[22]  J. V. Reed,et al.  Practical experience of minimisation in clinical trials , 1988 .

[23]  C B Begg,et al.  The impact of treatment allocation procedures on nominal significance levels and bias. , 1987, Controlled clinical trials.

[24]  B W Brown,et al.  Sequential treatment allocation procedures in clinical trials--with particular attention to the analysis of results for the biased coin design. , 1986, Statistics in medicine.

[25]  N. Birkett,et al.  Adaptive allocation in randomized controlled trials. , 1985, Controlled clinical trials.

[26]  C B Begg,et al.  Treatment allocation methods in clinical trials: a review. , 1985, Statistics in medicine.

[27]  Richard L. Smith Sequential Treatment Allocation Using Biased Coin Designs , 1984 .

[28]  C. Begg,et al.  Treatment allocation for nonlinear models in clinical trials: the logistic model. , 1984, Biometrics.

[29]  Titterington Dm,et al.  On constrained balance randomization for clinical trials. , 1983 .

[30]  S. Lagakos,et al.  Practical experience of randomization in cancer trials: an international survey. , 1982, British Journal of Cancer.

[31]  A. Atkinson Optimum biased coin designs for sequential clinical trials with prognostic factors , 1982 .

[32]  C B Begg,et al.  A treatment allocation procedure for sequential clinical trials. , 1980, Biometrics.

[33]  Brown Bw Designing for cancer clinical trials: selection of prognostic factors. , 1980 .

[34]  R. Simon,et al.  Restricted randomization designs in clinical trials. , 1979, Biometrics.

[35]  Pocock Sj,et al.  Allocation of patients to treatment in clinical trials. , 1979 .

[36]  Klotz Jh,et al.  Maximum entropy constrained balance randomization for clinical trials. , 1978 .

[37]  L. Freedman,et al.  Allocation of patients to treatment groups in a controlled clinical study. , 1978, British Journal of Cancer.

[38]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[39]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[40]  L S Freedman,et al.  On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. , 1976, Biometrics.

[41]  S. Pocock,et al.  Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.

[42]  D R Taves,et al.  Minimization: A new method of assigning patients to treatment and control groups , 1974, Clinical pharmacology and therapeutics.